Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks
IPO Activity healthcare-funding pharmaceutical investment-trends

Rubicon Research IPO: Key Details and Market Expectations Ahead of Oct. 9 Launch

Newsdesk profile image
by Newsdesk
Updated
Rubicon Research IPO: Key Details and Market Expectations Ahead of Oct. 9 Launch

AI-Generated Summary

Pharmaceutical formulation company Rubicon Research Ltd. is poised to launch its Initial Public Offering (IPO) from October 9-13, aiming to raise Rs 1,377.50 crore through a combination of fresh issue and offer-for-sale. The IPO's price band is set between Rs 461 and Rs 485 per share, with market indicators, including the Grey Market Premium (GMP), suggesting a potential listing gain exceeding 16%. Shares are scheduled to list on the BSE and NSE on October 16.

In a nutshell

This IPO represents a significant capital event for a pharmaceutical formulation company, providing crucial insights into investor confidence and market valuation within the healthcare sector. The strong grey market premium highlights robust investor appetite for established pharmaceutical entities seeking public funding and underscores current market sentiment.

Source: NDTV Profit

Newsdesk profile image
by Newsdesk
Updated

Be informed!

Rx.news delivers critical healthcare intelligence to pharmaceutical professionals, biotech innovators, healthcare investors, medical practitioners, and policy makers.

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More